Clinical Trial Update: Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase II study evaluating concurrent C225 (cetuximab), cisplatin, and radiation in stage IV head and neck squamous cell carcinoma completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• C225 (cetuximab) (cetuximab)
• CISPLATIN (cisplatin)
• Radiation therapy

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-03-25